CREATE: Chemotherapy for Rectal cancer bEfore or After local TrEatment. A pragmatic, UK led international phase III randomised trial comparing 12 weeks of chemotherapy either before or after standard local pelvic treatment in MRI defined operable rectal cancer at high risk of metastatic relapse